Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 2,188

Document Document Title
WO/2022/162471A1
Disclosed are compounds, compositions, and methods useful for treating neuronal and mitochondrial diseases.  
WO/2022/157274A1
The invention relates to a polymerizable photoinitiator, to a process for preparing a polymerizable photoinitiator, to a polymerizable composition comprising a polymerizable photoinitiator and an ethylenically unsaturated compound. The i...  
WO/2022/105845A1
A glucoside derivative, and a preparation method therefor and an application thereof. Specifically, provided is a glucoside derivative, which is a compound as represented by formula (I) or a pharmaceutically acceptable salt thereof. The ...  
WO/2022/091691A1
A compound having at least one group represented by general formula (11) and including only one benz[de]anthracene derivative skeleton represented by general formula (1000) in the molecule. Ar1 is a substituted or unsubstituted aryl grou...  
WO/2022/071116A1
A purpose of the present invention is to provide a thioxanthone compound having excellent reactivity to long-wavelength light. The present invention relates to a photopolymerization initiator comprising the thioxanthone compound, a curab...  
WO/2022/060020A1
The present invention relates to a novel organic electroluminescent compound and an organic electroluminescent device using same and, more specifically, to: a compound having excellent thermal stability, electrochemical stability, light-...  
WO/2022/054554A1
Provided is a highly active actinic-ray-sensitive acid generator which, upon irradiation with actinic rays, comes to have cationic-polymerization performance or crosslinking reaction performance and which enables curable compositions con...  
WO/2022/053845A1
With the present invention, a compound [OH-TX-S-]2, gold nanoparticles (AuNps) coated with a coating layer containing same, AuNPs synthesized with a PdI of 0.45±0.01 and a core diameter of 30±1 nm, and the versions thereof coated with ...  
WO/2022/025117A1
The present invention provides the compound represented in general formula (A1) [Ar1 is a C6-14 aryl group or a C5-14 nitrogen-containing heteroaryl group, substituted with at least two electron-attracting groups; R1 is a C1-30 alkyl gro...  
WO/2022/022372A1
Disclosed in the present invention are a thiobenzopyran compound as shown in formula I and an application of a pharmaceutically acceptable salt of the thiobenzopyran compound in preparation of a drug for treating rheumatoid arthritis, wh...  
WO/2022/018968A1
The present invention provides a useful photoacid generator which is contained in a photocurable composition, a chemically amplified positive photoresist composition and a chemically amplified negative photoresist composition, and which ...  
WO/2021/249566A1
Provided are a benzo six-membered ring derivative for treating liver fibrosis and use thereof. Specifically, provided are a compound as shown in formula (I), a pharmaceutical composition containing the compound of formula (I), and use of...  
WO/2021/246363A1
A purpose of the present invention is to provide a sealing agent for liquid crystal display elements, which has excellent curability at light shielded parts and which is capable of preventing gelling and thickening when dissolving a phot...  
WO/2021/226276A2
Provided are compounds of Formula (II): or a pharmaceutically acceptable salt thereof, wherein R1, n, and Y1 are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula (II), or a ph...  
WO/2021/204175A1
Provided herein are lipids that can be used in combination with other lipid components, such as neutral lipids, cholesterol and polymer conjugated lipids, to form lipid nanoparticles for delivery of therapeutic agents (e.g., nucleic acid...  
WO/2021/200179A1
The present invention provides an actinic-ray-sensitive or radiation-sensitive resin composition comprising (A) a resin which increases in polarity by the action of an acid and (B) a compound which generates an acid upon irradiation with...  
WO/2021/170913A1
Chemical modulators of PP2A, comprising tricyclic sulfonimidamides are disclosed. The compounds are useful in preventing or treating cancer, diabetes, autoimmune disease, solid organ transplant rejection, graft vs host disease, chronic o...  
WO/2021/159015A1
Provided are compounds of Formula (II) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, and p are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formul...  
WO/2021/149998A1
The present invention provides a novel compound, an organic electric element using same, and an electronic device having same, the novel compound capable of improving the light-emitting efficiency, stability and lifespan of the element.  
WO/2021/144582A1
Latent photoinitiator compounds are described, as well as compositions containing such compounds and their uses in photoinitated methods for producing photoresist structured.  
WO/2021/125834A1
The present invention provides: a novel compound capable of improving the light-emitting efficiency, stability and lifespan of an element; an organic electrical element using same; and an electronic device thereof.  
WO/2021/104506A1
A cyclic sulfone compound and a preparation method therefor, a pharmaceutical composition thereof and use thereof. Specifically, the cyclic sulfone compound and a pharmaceutically acceptable salt are represented by formula (I), and can b...  
WO/2021/103060A1
Disclosed are a hole transport material, a preparation method therefor, and an organic light emitting device, the hole transport material comprising a compound having a chemical structure represented by formula I, Z comprising a carbon a...  
WO/2021/103728A1
An organic compound and an organic electroluminescent device using the compound used for the field of organic electroluminescence. The organic compound is as shown in structural formula I, wherein Ar1 to Ar 4 are independently selected f...  
WO/2021/085372A1
An embodiment of the present invention pertains to a resin composition, a compound (Z), an optical filter, or a solid-state imaging device and optical sensor device using the optical filter. The resin composition contains a resin, and a ...  
WO/2021/064189A2
The present invention relates to novel compounds of formula (I) and pharmaceutical compositions containing these compounds. The compounds provided herein can act as prostaglandin E2 (PGE2) EP4 receptor antagonists, which renders them hig...  
WO/2021/066435A1
The present invention relates to a compound for an organic electric element, an organic electric element using same, and an electronic device comprising the organic electric element. According to the present invention, an organic electri...  
WO/2021/060276A1
Provided, inter alia, is a fluorinating agent that can selectively produce a monofluorination product through preferential synthesis of the monofluorination product over a difluorination product, in a fluorination reaction in which a flu...  
WO/2021/047525A1
The present invention relates to the technical field of medicine, and provides a salt of a benzothiopyrone compound, and a preparation method therefor and an application thereof, in particular, a salt of 2-(4-(cyclohexylmethyl)piperazin-...  
WO/2021/049470A1
The purpose of the present invention is to provide a compound having excellent acid generation sensitivity. The present invention is a compound represented by general formula (A) below. (In the formula, R11 and R20 each independently r...  
WO/2021/039654A1
The present invention provides: an active-ray-sensitive or radiation-sensitive resin composition having a solid material concentration of 10% by mass or more, the active-ray-sensitive or radiation-sensitive resin composition comprising a...  
WO/2021/029158A1
The purpose of the present invention is to provide: a sulfonamide compound which has a high decomposition rate in response to near-ultraviolet rays and which generates a superacid bis-sulfonamide, and which is highly soluble in a resist ...  
WO/2021/023119A1
Provided is a co-crystal formed by flupentixol dihydrochloride and melitracen hydrochloride, wherein the molar ratio of flupentixol dihydrochloride and melitracen hydrochloride in the co-crystal is 1:1. The co-crystal has a good stabilit...  
WO/2021/026179A1
The present invention is directed to compounds of the formula (I) wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositio...  
WO/2021/020429A1
The present invention provides a compound represented by formula (I) or a pharmaceutically acceptable salt thereof which has the effect of antagonizing the LPA1 receptor.  
WO/2020/261021A1
Described are polymerizable fused tricyclic compounds of formula I: wherein R1, R2, R3, m, n, t, and rings B, C, and D are as defined herein. The compounds absorb various wavelengths of ultraviolet and/or visible light (such as high ener...  
WO/2020/218680A1
The present invention relates to a novel organic light emitting compound and an organic electroluminescent diode using same and, more specifically, to: a compound having excellent thermal stability, electrochemical stability, light emitt...  
WO/2020/216777A1
The present invention relates to a composition comprising a compound of formula (I) wherein X is selected from the group consisting of S, Se, P, PO, SO, NR1, CR1, CR1R1 or C0-2-alkyl; Z is selected from the group consisting of hydrogen, ...  
WO/2020/159019A1
The present invention relates to a novel organic light-emitting compound and an organic electroluminescent device using same and, more specifically, to a compound having excellent thermal stability, electrochemical stability, light-emitt...  
WO/2020/158870A1
The purpose in one embodiment of the present invention is to provide a therapeutic for Parkinson's disease, etc. A compound represented by formulas (1), (2), or (8) or a pharmacologically acceptable salt thereof can be used in the treatm...  
WO/2020/151623A1
The present invention pertains to the medical field and relates to a compound of formula (III), a stereoisomer or pharmaceutically acceptable salt thereof. The present invention also relates to a method for preparing the compound, a ster...  
WO/2020/151621A1
The present invention belongs to the field of medicine, and specifically relates to a compound of formula (I), an isomer or a pharmaceutical salt thereof. This present invention more specifically relates to a compound, a stereoisomer the...  
WO/2020/153669A1
The present invention relates to a compound for an organic electric device, an organic electric device using same, and an electronic apparatus thereof. According to the present invention, high luminous efficiency, low driving voltage, an...  
WO/2020/145043A1
Provided are: a novel sulfonium salt which exhibits high photosensitivity to g rays or h rays; and a novel photoacid generator containing a sulfonium salt which exhibits high photosensitivity to g rays or h rays, high solubility in a sol...  
WO/2020/137921A1
The present invention provides an actinic light sensitive or radiation sensitive resin composition, a resist film, a pattern forming method, and an electronic device production method, wherein the actinic light sensitive or radiation sen...  
WO/2020/134138A1
The present disclosure relates to the technical field of luminescent materials, and relates in particular to an organic electroluminescent compound, a preparation method therefor and an organic electroluminescent device. In order to solv...  
WO/2020/109132A1
A radiation curable inkjet ink comprising a polymerizable compound and a photoinitiator, characterized in that the photoinitiator comprises a functional group selected from the group consisting of an aliphatic thio-ether and an aliphatic...  
WO/2020/086691A1
This current disclosure is directed to charge-transfer heptamethine dyes for NIR singlet oxygen generation, each such dye comprising a near-infrared (NIR) absorbing dye having heptamethine linkages orthogonally coupled to an optionally s...  
WO/2020/067118A1
A dialkyl peroxide including a thioxanthone group, characterized by being represented by general formula (1) (wherein R1, R2, R3, and R4 each independently represent a methyl or ethyl group; R5 represents a C1-6 alkyl group or a phenyl g...  
WO/2020/052774A1
The application provides flavone derivatives having the general formula (I) which are useful for the treatment of Hepatitis B Virus infection (HBV). The compounds act as cccDNA (covalently closed circular DNA) inhibitors.  

Matches 1 - 50 out of 2,188